Polar Capital Healthcare Opports I Inc
HealthcarePricing frequency
Daily
Dealing cut off time
13:00
Type
OEIC
Yield
-
NAV
£59.44
Ongoing charge
1.11%
Latest actual NAV date
22-04-2024
ISIN
IE00B3NLDF60
UCITS
Yes
This fund can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 29/02/2024 | % of assets |
|---|---|
| Zealand Pharma A/S | 12.10 |
| Swedish Orphan Biovitrum AB | 8.97 |
| Sanofi SA | 4.01 |
| Intuitive Surgical Inc | 3.99 |
| Cytokinetics Inc | 3.97 |
| UCB SA | 3.69 |
| Max Healthcare Institute Ltd Ordinary Shares | 3.58 |
| argenx SE | 3.56 |
| HCA Healthcare Inc | 3.52 |
| MEDLEY Inc Ordinary Shares | 3.15 |
Investment objective
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of healthcare companies. The Fund will at all times invest at least two thirds of its total assets (excluding cash) in healthcare-related companies worldwide. The Fund will invest at least 51% of its gross assets on a continuous basis directly in Equity Participations. Subject to the investment restrictions described in Appendix II of the Prospectus, investments will be made in transferable securities including, but not limited to, shares, equity warrants and other types of securities such as preferred shares, which may be listed on a Regulated Market or unlisted, and issued by companies, and Global, American and European depository receipts. The Fund may not invest more than 10% of its Net Asset Value in unlisted securities.
Morningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.